The RECAP Trial 1.0

  • Research type

    Research Study

  • Full title

    Rehabilitation through Exercise prescription for Cardiac patients using an Artificial Intelligence based Programme - RECAP

  • IRAS ID

    315483

  • Contact name

    Enoch Akowuah

  • Contact email

    enoch.akowuah@nhs.net

  • Sponsor organisation

    South Tees Hospitals NHS FT

  • ISRCTN Number

    ISRCTN97352737

  • Duration of Study in the UK

    1 years, 6 months, 7 days

  • Research summary

    Cardiac rehabilitation helps patients improve their physical activity levels after surgery and heart attacks. It has been shown to reduce hospital readmission rates and reduce the risk of death in the long term.

    Traditionally cardiac rehabilitation has been offered to patients via classroom-based classes. However, some patients may prefer not to attend hospital-based sessions due to the availability of transport and the risk of infection including COVID-19. One of the long-term goals of the NHS is to move outpoints’ appointments to the remote setting. This will also be cost-effective and save time for both the patient as well as the hospital.

    This study aims to assess the feasibility of delivering an automated home-based rehabilitation programme using physical activity monitors and a mobile app. In this study, exercise goals will be prescribed for patients, considering factors such as their age, height, weight, and activity levels at any given time. These personalised goals will dynamically change as their activity levels changes.

    We created a mobile app that can be installed on the patients’ mobile devices. We will use accelerometers to track the physical activity of the patients including their step count, calorie expenditure and sedentary times. These are devices that look like a watch, similar to a Fitbit, which the patients will wear on their wrist, and it will wirelessly transmit the information collected to the app. Through the app, they can then view their activity levels and view their weekly goals.

    This study will be done in two phases (phase I will recruit 20 patients and phase II, 70 patients). At the end of the study, we will see how practical this technology is by looking at outcomes including user satisfaction, intent of continue use, and appropriateness.

  • REC name

    South Central - Berkshire Research Ethics Committee

  • REC reference

    22/SC/0262

  • Date of REC Opinion

    5 Sep 2022

  • REC opinion

    Further Information Favourable Opinion